Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Heatmap
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
VERA
#1677
Vera Therapeutics, Inc. Class A Common Stock
43.420
0
USD
-2.12%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
-2.12%
Mudança mensal
+7.02%
Mudança em 6 meses
+46.00%
Mudança anual
+46.00%
Fechamento anterior
44.360
0
Abrir
43.650
0
Bid
Ask
Mínimo
43.105
0
High
43.650
0
Volume
697
Mercados
Ações
Cuidados de saúde
VERA
Abrir gráfico completo
Financials
Visão geral
Relatórios
Estatísticas
Trimestral
Ano
Valor
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
63.75 M
63.77 M
63.82 M
63.89 M
71.36 M
—
Valuation ratios
Enterprise value
2.66 B
1.53 B
1.53 B
1.88 B
3.35 B
8.29 B
Price to earnings ratio
-15.38
-8.01
-6.58
-7.28
-10.87
-32.74
Price to sales ratio
601.64
354.32
518.04
806.96
7 992.14
9 671.46
Price to cash flow ratio
-17.37
-8.94
-7.62
-8.57
-13.49
-38.61
Price to book ratio
4.05
0.8
0.75
0.9
5.5
7.94
Enterprise value to EBITDA ratio
-16.29
-8.09
-6.57
-7.01
-10.65
-32.32
Profitability ratios
Return on assets %
-0.07
-0.08
-0.13
-0.16
-0.12
-0.5
Return on equity %
-0.08
-0.1
-0.16
-0.2
-0.15
-0.61
Return on invested capital %
-2 450.51
—
—
—
-5 768.91
—
Gross margin %
100
100
100
100
100
400
Operating margin %
-4 069.38
-6 462.6
23.78 K
-23.19 K
18.73 K
12.86 K
EBITDA margin %
-3 964.81
-6 352.99
23.85 K
-23.05 K
18.8 K
13.24 K
Net margin %
-3 612.73
-5 841.13
22.71 K
-22.18 K
18.11 K
12.8 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
25.67
27.68
17.03
12.21
13.64
70.55
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
-0
0
-0
0
Solvency ratios
Debt to assets ratio
0.08
0.09
0.13
0.15
0.11
0.48
Debt to equity ratio
0.09
0.1
0.17
0.19
0.13
0.59
Long term debt to total assets ratio
0.08
0.08
0.13
0.14
0.1
0.46
Long term debt to total equity ratio
0.09
0.1
0.16
0.19
0.12
0.57
Per share metrics
Operating cash flow per share
-0.71
-0.85
-0.86
-0.97
-1.09
-3.77
EBIT per share
-0.86
-0.88
-1.26
-1.31
-1.47
-4.93
EBITDA per share
-0.86
-0.88
-1.26
-1.31
-1.47
-4.92
Total debt per share
0.99
0.86
1.22
1.21
1.2
4.48
Cash per share
11.58
9.26
8.73
7.79
11.12
36.91
Net current asset value per share
11.77
9.52
8.96
8.01
11.35
37.83
Tangible book value per share
10.43
8.4
7.34
6.25
9.21
31.2
Working capital per share
11.31
9.17
8.43
7.35
10.52
35.47
Book value per share
10.43
8.4
7.34
6.25
9.21
31.2
Notícias
Vera Therapeutics nomeia Jane Wright-Mitchell como diretora jurídica
Wolfe Research eleva rating das ações da Vera Therapeutics com base na avaliação
Wolfe Research upgrades Vera Therapeutics stock rating on valuation
BofA Securities reafirma classificação de compra para Vera Therapeutics
Vera Therapeutics stock rating reaffirmed at Buy by BofA Securities
Vera Therapeutics, Inc. (VERA) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Vera Therapeutics nomeia Christopher Hite para o conselho de administração
Vera Therapeutics adds Christopher Hite to board of directors
3 Best Stocks With 125%+ Upside Ahead, According to Top Analysts, 3/2/2026 - TipRanks.com
Vera Therapeutics: Hold Rating Based On Potential For Atacicept In IgAN (Rating Downgrade)
VeraDermics is said to draw IPO anchor order from Eli Lilly - Bloomberg
Vera Therapeutics promove Matt Skelton a diretor comercial